Cite
HARVARD Citation
Feagan, B. et al. (2015). Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease. Alimentary pharmacology & therapeutics. 42 (10), pp. 1170-1181. [Online].